COVID-19 and geriatric clinical trials research

Elizabeth K. Rhodus, Shoshana H. Bardach, Erin L. Abner, Allison Gibson, Gregory A. Jicha

Research output: Contribution to journalArticlepeer-review

4 Scopus citations
Original languageEnglish
Pages (from-to)2169-2172
Number of pages4
JournalAging clinical and experimental research
Volume32
Issue number10
DOIs
StatePublished - Oct 1 2020

Bibliographical note

Funding Information:
The first author is funded by NIH T32 AG057461: “Training in Translational Research in Alzheimer’s and Related Dementias (TRIAD)”. All authors are affiliated with University of Kentucky Alzheimer’s Disease Cohort participants funded by NIH/NIA P30 AG028383.

Funding Information:
Given the heightened public interest in advancing scientific and medical initiatives to combat the COVID-19 crisis, as well as the financial burden the crisis is posing globally, there is increasing competition for resources that have long been lacking in the field. Funding increases for aging-related research were moving at a rapid pace but funds now may be in jeopardy with this competing need. Large-scale funding from the NIH is being redirected to directly combat the COVID-19 pandemic. While immediate repercussions on the budget for National Institute on Aging has not yet occurred, we hope that specific aging-related research continues to receive the funds necessary to move the field forward. Representation and advocacy for aging science by stakeholders is imperative to protect current availability of geriatric clinical trial research.

Keywords

  • COVID-19
  • Clinical Trails
  • Research

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Fingerprint

Dive into the research topics of 'COVID-19 and geriatric clinical trials research'. Together they form a unique fingerprint.

Cite this